Literature DB >> 33419257

Ionic Environment Affects Biomolecular Interactions of Amyloid-β: SPR Biosensor Study.

Erika Hemmerová1, Tomáš Špringer1, Zdeňka Krištofiková2, Jiří Homola1.   

Abstract

In early stages of Alzheimer's disease (AD), amyloid beta (Aβ) accumulates in the mitochondrial matrix and interacts with mitochondrial proteins, such as cyclophilin D (cypD) and 17β-hydroxysteroid dehydrogenase 10 (17β-HSD10). Multiple processes associated with AD such as increased production or oligomerization of Aβ affect these interactions and disbalance the equilibrium between the biomolecules, which contributes to mitochondrial dysfunction. Here, we investigate the effect of the ionic environment on the interactions of Aβ (Aβ1-40, Aβ1-42) with cypD and 17β-HSD10 using a surface plasmon resonance (SPR) biosensor. We show that changes in concentrations of K+ and Mg2+ significantly affect the interactions and may increase the binding efficiency between the biomolecules by up to 35% and 65% for the interactions with Aβ1-40 and Aβ1-42, respectively, in comparison with the physiological state. We also demonstrate that while the binding of Aβ1-40 to cypD and 17β-HSD10 takes place preferentially around the physiological concentrations of ions, decreased concentrations of K+ and increased concentrations of Mg2+ promote the interaction of both mitochondrial proteins with Aβ1-42. These results suggest that the ionic environment represents an important factor that should be considered in the investigation of biomolecular interactions taking place in the mitochondrial matrix under physiological as well as AD-associated conditions.

Entities:  

Keywords:  17β-hydroxysteroid dehydrogenase 10 (17β-HSD10); amyloid beta (Aβ); biomolecular interactions; cyclophilin D (cypD); ionic environment; mitochondrial matrix; surface plasmon resonance (SPR)

Mesh:

Substances:

Year:  2020        PMID: 33419257      PMCID: PMC7766583          DOI: 10.3390/ijms21249727

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  41 in total

Review 1.  The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives.

Authors:  Russell H Swerdlow; Jeffrey M Burns; Shaharyar M Khan
Journal:  Biochim Biophys Acta       Date:  2013-09-23

2.  Kinetic characterization of amyloid-beta 1-42 aggregation with a multimethodological approach.

Authors:  Manuela Bartolini; Marina Naldi; Jessica Fiori; Francesco Valle; Fabio Biscarini; Dan V Nicolau; Vincenza Andrisano
Journal:  Anal Biochem       Date:  2011-03-22       Impact factor: 3.365

Review 3.  [What we don't know about mitochondrial potassium channels?]

Authors:  Bartłomiej Augustynek; Antoni Wrzosek; Piotr Koprowski; Agnieszka Kiełbasa; Piotr Bednarczyk; Agnieszka Łukasiak; Krzysztof Dołowy; Adam Szewczyk
Journal:  Postepy Biochem       Date:  2016

Review 4.  Mitochondrial permeability transition pore is a potential drug target for neurodegeneration.

Authors:  Valasani Koteswara Rao; Emily A Carlson; Shirley Shidu Yan
Journal:  Biochim Biophys Acta       Date:  2013-09-18

5.  Solution NMR studies of the A beta(1-40) and A beta(1-42) peptides establish that the Met35 oxidation state affects the mechanism of amyloid formation.

Authors:  Liming Hou; Haiyan Shao; Yongbo Zhang; Hua Li; Nanda K Menon; Elizabeth B Neuhaus; John M Brewer; In-Ja L Byeon; Dale G Ray; Michael P Vitek; Takashi Iwashita; Ronald A Makula; Alan B Przybyla; Michael G Zagorski
Journal:  J Am Chem Soc       Date:  2004-02-25       Impact factor: 15.419

6.  Possible role of amyloid-beta, adenine nucleotide translocase and cyclophilin-D interaction in mitochondrial dysfunction of Alzheimer's disease.

Authors:  Prabhakar Singh; Shubhankar Suman; Sudhir Chandna; Taposh Kumar Das
Journal:  Bioinformation       Date:  2009-08-04

Review 7.  Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease.

Authors:  P Hemachandra Reddy
Journal:  Exp Neurol       Date:  2009-04-07       Impact factor: 5.330

Review 8.  Alzheimer's disease and the amyloid-beta peptide.

Authors:  M Paul Murphy; Harry LeVine
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 9.  Oxidative stress, protein modification and Alzheimer disease.

Authors:  A Tramutola; C Lanzillotta; M Perluigi; D Allan Butterfield
Journal:  Brain Res Bull       Date:  2016-06-15       Impact factor: 4.077

10.  Natural amyloid-β oligomers acutely impair the formation of a contextual fear memory in mice.

Authors:  Kara A Kittelberger; Fabrizio Piazza; Giuseppina Tesco; Leon G Reijmers
Journal:  PLoS One       Date:  2012-01-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.